HLB PANAGENE Co., LTD. Company Description

HLB PANAGENE Co., LTD. develops products in the field of molecular diagnostics in South Korea. Its products include liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases.

The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products.

The company was formerly known as Panagene Inc. and changed its name to HLB PANAGENE Co., LTD. in August 2023.

HLB PANAGENE Co., LTD. was incorporated in 1976 and is based in Daejeon, South Korea.

HLB PANAGENE Co., LTD.

Country	South Korea
Founded	1976
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	63
CEO	Sung-Ki Kim

Contact Details

Address: 54, Techno 10-ro Daejeon, 34027 South Korea
Phone	82 4 2861 9295
Website	panagene.com

Stock Details

Ticker Symbol	046210
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835

Key Executives

Name	Position
Sung-Ki Kim	Chief Executive Officer